Steris | STE - Current Liabilities


Steris reported $1.28B in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
3M USD 11.87B 489M Sep/2026
Accuray USD 199.44M 4.83M Dec/2025
Baxter International USD 3.59B 102M Jun/2026
Becton, Dickinson and Co. USD 9.4B 897M Jun/2026
Boston Scientific USD 6.43B 1.86B Jun/2026
CONMED USD 455.4M 162.68M Jun/2026
Cooper Companies USD 1.87B 61.9M Jun/2026
Dexcom USD 2.36B 133.9M Jun/2026
Ecolab USD 5.99B 109.1M Jun/2026
Edwards Lifesciences USD 1.51B 98.9M Jun/2026
Fortive USD 1.29B 898.7M Jun/2026
Getinge SEK 12.03B 3.01B Jun/2026
Globus Medical USD 479.35M 3.12M Jun/2026
Haemonetics USD 263.24M 19.36M Jun/2026
Idexx Laboratories USD 1.29B 12.19M Jun/2026
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 744.2M 56.7M Jun/2026
Integra LifeSciences USD 329M 1.88M Sep/2026
Intuitive Surgical USD 3.23B 652.4M Sep/2026
J&J USD 55.46B 562M Sep/2026
Olympus JPY 467.38B 30.5B Jun/2026
Orthofix International USD 157.01M 4.02M Jun/2026
Owens Minor USD 666.22M 536.89M Jun/2026
ResMed USD 1.4B 43.9M Jun/2026
Steris USD 1.28B 138.3M Jun/2026
Stryker USD 6.68B 369M Jun/2026
Tandem Diabetes Care USD 253M 5.05M Jun/2026
Teleflex USD 720.38M 7.67M Jun/2026
Thermo Fisher Scientific USD 14.17B 899M Sep/2026
Zimmer Biomet Holdings USD 3.01B 149.2M Jun/2026